Learning Objectives
1. Describe the changes in the lungs and resulting signs and symptoms that occur in asthma.
2. Identify various triggers for asthma.
3. Discuss inhaler techniques for various inhaler devices.
4. Recognize the common adverse effects of the most frequently used medications for the treatment of asthma.
5. Define the vaccine preventable illnesses for which patients with asthma are prone.
Author
Julie A. Murphy, PharmD, FASHP, FCCP, BCPS
Associate Professor/Internal Medicine Clinical Pharmacy Specialist
University of Toledo College of Pharmacy and Pharmaceutical Sciences
Toledo, OH
This module will provide 2.5 contact hours (0.25 CEUs) of continuing pharmacy education credit for pharmacy technicians.
ACPE UAN 0121-0000-22-002-H01-T
Activity Type: Knowledge-based
Release date: April 1, 2022
Expiration date: March 31, 2025
November 11, 2022 - Correction
An error has been identified in the module titled Asthma: A Treatment and Delivery Device Update - Volume 27 No. 2.
The error is on page 12 of your module in Table 11. Short-Acting B2-Adrenergic Agonist Comparison. The error is in the third row of products (Albuterol nebulizer solution), column 3. It currently states 2-11 years and should state 5-11 years. A corrected table is shown below.
The module pdf has been updated on PharmacyTechTopics.com if you would like to download the new version. To do this, simply log in to your PTT account and click on "My Modules." You are also able to download a revised copy of page 12 to print and/or save for your records by clicking this
link.
